Differential effects of beta-adrenoreceptor antagonists on central and peripheral blood pressure at rest and during exercise.
BACKGROUND
Differential effects of beta-adrenoreceptor antagonists (beta-ARB) on central and peripheral blood pressure may relate to change in heart rate and/or vasodilator tone and thus be exaggerated during exercise.


OBJECTIVE
To examine acute effects of selective and nonselective beta-ARB on central and peripheral blood pressure, cardiac output and peripheral vascular resistance during exercise.


METHODS
Healthy volunteers (n= 20, 18 men, 19-54 years) received propranolol 80 mg, bisoprolol 20 mg, and placebo 1 h before bicycle ergometry (50, 75 and 100 W each for 3 min) in a randomized, cross-over study. Cardiac output was determined by pulmonary uptake of soluble and inert gas tracers (InnoCor, Innovision). Central systolic blood pressure (SBP) was determined from the late systolic shoulder of the digital artery pressure waveform (Finometer, Finopres).


RESULTS
At rest, both beta-ARB reduced brachial but not central SBP (compared with placebo). During exercise, beta-ARB reduced brachial SBP (reductions of 19.9 +/- 4.3 mmHg and 23.2 +/- 2.7 mmHg for propranolol and bisoprolol, respectively, at 100 W, each P < 0.0001) but not central SBP. The difference between peripheral and central SBP was reduced, relative to that during placebo, by 21.5 mmHg (95% confidence interval 8.8, 34.1) and 26.4 mmHg (18.1, 34.8) for propranolol and bisoprolol, respectively, at 100 W (each P < 0.01). There was no significant effect of beta-ARB on diastolic blood pressure or peripheral vascular resistance.


CONCLUSIONS
Despite reducing brachial blood pressure, acute beta-adrenoreceptor blockade in man at rest and during exercise does not reduce central blood pressure.
Cockburn
James A
JA
King's College London School of Medicine, Department of Clinical Pharmacology, St Thomas' Hospital, London, UK.
Brett
Sally E
SE
Guilcher
Antoine
A
Ferro
Albert
A
Ritter
James M
JM
Chowienczyk
Philip J
PJ
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D000959:Antihypertensive Agents / Q000494:pharmacology*; D017298:Bisoprolol / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects*; D001916:Brachial Artery / Q000187:drug effects; D018592:Cross-Over Studies; D003971:Diastole; D004311:Double-Blind Method; D015444:Exercise / Q000502:physiology*; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000494:pharmacology*; D013599:Systole; D014655:Vascular Resistance / Q000187:drug effects; D055815:Young Adult
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D011433:Propranolol; D017298:Bisoprolol
Hypertension. 2008 Jan;51(1):112-8
17998476
Br J Clin Pharmacol. 1986 Sep;22(3):293-300
2876722
Am J Hypertens. 2002 Jan;15(1 Pt 1):24-30
11824855
Z Kardiol. 1978 Dec;67(12):857-62
735294
J Hum Hypertens. 2003 Feb;17(2):81-6
12574784
Hypertension. 2000 Dec;36(6):952-6
11116106
Circulation. 1991 Sep;84(3):1049-57
1653122
Curr Opin Cardiol. 2005 Jul;20(4):275-81
15956823
J Hypertens. 2001 Aug;19(8):1343-8
11518841
Circulation. 2000 Feb 15;101(6):611-5
10673252
J Am Coll Cardiol. 2004 Jan 7;43(1):92-9
14715189
Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1645-50
18296568
J Biol Chem. 1999 Jun 11;274(24):16694-700
10358008
J Appl Physiol (1985). 1994 Jun;76(6):2832-9
7928918
Circulation. 1997 May 6;95(9):2293-7
9142007
Hypertension. 1994 Jul;24(1):56-62
8021008
Circulation. 2006 Mar 7;113(9):1213-25
16476843
Hypertension. 2001 Oct;38(4):922-6
11641310
Br J Anaesth. 2004 May;92(5):651-7
15003985
BMJ. 2004 Mar 13;328(7440):634-40
15016698
Lancet. 2005 Oct 29-Nov 4;366(9496):1545-53
16257341
Am J Hypertens. 2004 Feb;17(2):118-23
14751652
Br J Clin Pharmacol. 1988 Feb;25(2):169-77
2896013
J Physiol. 2000 May 15;525 Pt 1:263-70
10811742